MIT

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2023 Financial Results

Retrieved on: 
Monday, April 1, 2024
Hydrogen, MGH, Health, Hydrogen peroxide, Sale, Restaurant, Ionization, RELX, International, Webcast, Education, Harvard University, Food industry, GPO, Holiday, Global Biorisk Advisory Council, Academic Medical Center (Amsterdam), Police, Meat, Completion, Transport, Decontamination, Medication, AALAS, American Biological Safety Association, Research, Hospital, Food, ISSA, BIT, CES, Disinfectant, Conference, Horsepower, Growth, Assistant, MIT, Executive, School, Infection, DARPA, Environmental Health (journal), Raymond Castellani, Health care

FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.

Key Points: 
  • FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.
  • Financial Results for the year ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $7,355,000 compared to $8,338,000.
  • Financial Results for the three months ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $1,528,000 compared to $2,812,000.
  • TOMI will hold a conference call to discuss Fourth Quarter and year end 2023 results at 4:30 p.m.

Nvelop Therapeutics Launches with Dual Platforms for In Vivo Delivery of the Next Generation of Genetic Medicines

Retrieved on: 
Tuesday, April 9, 2024
Research, Medical Supplies, Infectious Diseases, Genetics, Biotechnology, Other Health, Health, Pharmaceutical, Science, Culture, Broad Institute, Cell, Massachusetts General Hospital, Partner (business rank), Environment, Trust, RNP, MIT, Spark Therapeutics, Patient, Harvard University, Nature Biotechnology, Tissue, Head, Protein, Therapy, Former, Safety, Royal Naval Patrol Service, FDA, Management

Nvelop Therapeutics , a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today formally announced its launch to develop the next generation of genetic medicines for a wide range of diseases.

Key Points: 
  • Nvelop Therapeutics , a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today formally announced its launch to develop the next generation of genetic medicines for a wide range of diseases.
  • The company’s approach has the potential to enable highly efficient and cell-specific delivery of a broad set of therapeutic cargoes.
  • “The field of genetic medicine is significantly limited by the challenge of efficiently delivering therapeutic cargoes to many types of target cells in vivo,” said Jeff Walsh, Nvelop’s Chief Executive Officer.
  • In vivo data for the second platform is expected to be disclosed at one or more scientific meetings this year.

Ikigai Labs’ Generative AI Platform Now Available in AWS Marketplace

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Security, Technology, Software, Artificial Intelligence, Internet, CRM, ROI, Forecasting, Learning, MIT, ERP, LGM, Research, AI, AWS, Architecture, Amazon Web Services, API, Feedback, Sales

AWS customers will now have seamless access to a powerful platform driving predictive and actionable insights in their trusted AWS Marketplace .

Key Points: 
  • AWS customers will now have seamless access to a powerful platform driving predictive and actionable insights in their trusted AWS Marketplace .
  • The Ikigai platform provides AWS customers with the ability to streamline the purchase and management of Ikigai Labs’ AI platform and solutions in their AWS Marketplace account.
  • Ikigai Labs’ availability through AWS Marketplace now empowers enterprises to transform their valuable enterprise data into business outcomes quickly – all through out-of-the-box, API toolkits and low-code/no-code AI models trained on their own data.”
    Ikigai Labs is now generally available in AWS Marketplace.
  • For more information on Ikigai Labs and its generative AI platform, please visit https://www.ikigailabs.io .

The South End Technology Center and The Mary J Harris Foundation Partner to Further Mel King's Vision

Retrieved on: 
Tuesday, April 9, 2024
Health, Health literacy, Attention, Partnership, MIT, SVB, Patient, City, Social Problems, Quality of life, MBA, Silicon, Silicon Valley Bank

BOSTON, April 9, 2024 /PRNewswire/ -- The South End Technology Center and the Mary J. Harris Foundation, Inc. announced their commitment to providing technology education and access with specific attention towards health and life sciences. Underserved populations historically suffer the brunt of systemic imbalances and disparities. In areas faced with wide social determinants of health, a center of support is necessary for a quality of life. Their partnership follows the vision of utilizing innovative technology and digital strategies to address complex social problems and drive systemic change.

Key Points: 
  • BOSTON, April 9, 2024 /PRNewswire/ -- The South End Technology Center and the Mary J. Harris Foundation, Inc. announced their commitment to providing technology education and access with specific attention towards health and life sciences.
  • In areas faced with wide social determinants of health, a center of support is necessary for a quality of life.
  • Their partnership follows the vision of utilizing innovative technology and digital strategies to address complex social problems and drive systemic change.
  • The South End Technology Center founded by the late MIT Professor, Political figure and Activist Mel King, originated as a space to start the gateway for equal access into the technology era.

MIT Technology Review's signature AI conference, EmTech Digital, comes to London April 16-17, 2024

Retrieved on: 
Tuesday, April 9, 2024
Renew Europe, European Parliament, Business, MIT, Ethics, Meta, Research, National Cyber Security Centre, Democracy, Life, MIT Technology Review, Legacy of Alan Turing, Parliament, European, Safety, Intelligence, Artificial Intelligence Act, Alan Turing Institute, Government, Policy, NCSC, Assistant professor, Medical device

CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- For the first time MIT Technology Review brings its signature AI conference, EmTech Digital, to Europe from 16-17 April in London, United Kingdom. Joining MIT Technology Review's editorial experts on the stage are leaders from Google DeepMind, Meta, BT, the Alan Turing Institute, the European Parliament, and the UK government. This conference will look at harnessing the power of AI and innovation through the lens of safety and global challenges.

Key Points: 
  • MIT's largest AI conference comes to London for the first time, as generative AI continues to dominate the public consciousness and questions surrounding ethics and responsibility grow.
  • CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- For the first time MIT Technology Review brings its signature AI conference, EmTech Digital , to Europe from 16-17 April in London, United Kingdom.
  • Joining MIT Technology Review's editorial experts on the stage are leaders from Google DeepMind, Meta, BT, the Alan Turing Institute, the European Parliament, and the UK government.
  • The two-day conference will be in-person in City of London, London and on-demand for attendees from around the world.

2024 Vault Rankings: Kmind Tops“Best Consulting Firms in Asia-Pacific for Innovation”

Retrieved on: 
Wednesday, March 20, 2024
Bull, Organization, Growth, MIT, Harvard Business Publishing, USD, Bain & Company, Canada China Business Council, Management

Beijing, China, March 20, 2024 (GLOBE NEWSWIRE) -- Recently, Vault announced that Kmind Consulting was honored the first place in Vault Ranking’s“2024 Best Consulting Firms in Asia-Pacific for Innovation”,becoming the first Chinese consulting firm to top this list.

Key Points: 
  • Beijing, China, March 20, 2024 (GLOBE NEWSWIRE) -- Recently, Vault announced that Kmind Consulting was honored the first place in Vault Ranking’s“2024 Best Consulting Firms in Asia-Pacific for Innovation”,becoming the first Chinese consulting firm to top this list.
  • Alongside Bain & Company and Roland Berger, Kmind is the first and only Chinese consulting firm to be feautred in “Top Consulting Firms in Asia-Pacific”, coming in at No.7.
  • Since Kmind’s notable entry in the 2023 Vault rankings, Kmind has been rapidly gaining international acclaim.
  • In June 2023, Kmind became the first Chinese consulting firm to share its strategy insights at Harvard Club, Brown University and MIT.

Repligen Appoints Maggie A. Pax to Board of Directors

Retrieved on: 
Tuesday, March 19, 2024
College, Innovation, Growth, Life Technologies, Repligen, Business, MIT, Thermo Fisher Scientific, Harvard Business School, Strategic planning, Business development, Acquisition, Massachusetts Institute of Technology, MBA, Marketing, Holy Cross, Alimera Sciences, Corporation, Management

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax.

Key Points: 
  • WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax.
  • Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for global companies.
  • Karen A. Dawes, Chairperson of the Board of Directors for Repligen, said, “We’re very happy to welcome Maggie Pax as a terrific addition to the Repligen Board with extensive experience in the life sciences industry.
  • Hunt, Chief Executive Officer for Repligen said, “Maggie understands first-hand the drivers of growth for our industry and has touched many of the focus areas for Repligen: key account programs, continuous innovation and M&A integration.

EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research

Retrieved on: 
Tuesday, March 12, 2024
Research, Neurology, Harvard Medical School, Synthetic media, Machine learning, Government, Regeneration, Prevalence, Massachusetts General Hospital, Science, Environment, MIT, Data science, SAN, Knowledge, Biomarker, History, Hope, Doctor of Philosophy, LLM, Vision 2030, Hub, Ecosystem, Drug development, Navar, Frontotemporal dementia, Artificial intelligence, Generative, Mass, Medicine, Medical device

The Vision 2030 AI Hub will have a laser focus on "repair and regeneration," aiming to distinguish the organization in the ALS research landscape.

Key Points: 
  • The Vision 2030 AI Hub will have a laser focus on "repair and regeneration," aiming to distinguish the organization in the ALS research landscape.
  • The Vision 2030 AI Hub epitomizes this momentous convergence—where the cumulative advances in ALS research and technology coalesce, heralding a new epoch of hope and discovery.
  • The Vision 2030 AI Hub motivates giving and fundraising, showcasing an innovative operating model that emphasizes urgency in tackling ALS and other disorders.
  • For more information about EverythingALS, Vision 2030, and the AI Hub visit http://www.v2030.org or email us at [email protected] .

Archetype AI Introduces Foundation Model to Pioneer Physical AI

Retrieved on: 
Friday, April 5, 2024
Hardware, Other Technology, Technology, Artificial Intelligence, Software, Organization, Intelligence, Internet of things, MIT, Infineon Technologies, Archetype, Perception, Software design, Engineering, Stanford University, Human, Samsung, NASA, The Walt Disney Company, Thermometer, Venrock, Sony, Language, Machine learning, ATAP

Archetype AI , a physical AI company helping humanity make sense of the world, today announced its emergence from stealth and the introduction of Newton™, a first-of-its-kind foundation model that understands the physical world.

Key Points: 
  • Archetype AI , a physical AI company helping humanity make sense of the world, today announced its emergence from stealth and the introduction of Newton™, a first-of-its-kind foundation model that understands the physical world.
  • With Newton, Archetype AI is introducing a first-of-its-kind physical AI foundational model that is capable of perceiving, understanding and reasoning about the world.
  • “The biggest problems in the world are physical, not digital,” said Ivan Poupyrev, CEO and co-founder of Archetype AI.
  • “The ambition of what Archetype AI is building can’t be underestimated – their physical AI model serves the ‘trillion sensor economy,’ and the use cases are nearly endless,” said Gayathri Radhakrishnan, Partner at Hitachi Ventures.

Cushman & Wakefield Selected by MIT for Generative AI and the Work of the Future Study

Retrieved on: 
Friday, April 5, 2024
Professional Services, Other Professional Services, Technology, Other Construction & Property, Commercial Building & Real Estate, Construction & Property, Artificial Intelligence, Synthetic media, Google.org, Generation, Organization, Work, Liberty Mutual, Digital, MIT, Research, AI, Faculty, IBM, Student, CWK, Future, Cushman & Wakefield, Workforce, Information officer, Feedback, Generative, IPC

Cushman & Wakefield (NYSE: CWK) announced today that the commercial real estate services firm will participate in the MIT Working Group on Generative AI and the Work of the Future.

Key Points: 
  • Cushman & Wakefield (NYSE: CWK) announced today that the commercial real estate services firm will participate in the MIT Working Group on Generative AI and the Work of the Future.
  • This initiative, led by the Massachusetts Institute of Technology (MIT), aims to explore the implications of generative AI on the future of work.
  • Generative AI tools have sparked widespread interest and debate regarding their potential to revolutionize various industries, from technology to customer service.
  • Cushman & Wakefield joins esteemed companies such as IBM and Liberty Mutual in this endeavor, demonstrating a collective commitment to embracing AI to shape the future of work.